Assessment Services

Drug & Device Development Service

The MCHRI Drug & Device Development Service was established to provide direct assistance to investigators in every stage of medical product development. Ensuring the project is on track, is targeting a robust market, and inclusive of all elements for regulatory approval are critical fundamentals which serve to expedite the translation of a health technology into the clinical setting.

Typical assessment services include:

Project management

  • Roadmap creation & timeline development
  • Project budgeting & cost tracking
  • Centralized point of contact

Regulatory strategy development

  • Target Product Profile creation
  • Pre-clinical development planning
  • Identification of pathways from bench to bedside

Market analysis & assessment

  • Clinical need assessment
  • Market sizing
  • Competition & trend analysis


Grant Wells, MS
Director of Innovation & Development